Ceruletide improves event-related potential indicators of cognitive processing in young but not in elderly humans

Journal of Clinical Psychopharmacology

Volumn 16, Issue 6, 1996, Pages 440-445

  Dodt, Christoph ^a   Sarnighausen, Hans Eckart ^a   Pietrowsky, Reinhard ^a   Fehm, Horst Lorenz ^a   Born, Jan ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CERULETIDE; CERULETIDE DIETHYLAMINE; CHOLECYSTOKININ DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; COGNITION; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EVOKED RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEMORY; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AGING; BLOOD PRESSURE; CAERULEIN; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; NOOTROPIC AGENTS; REACTION TIME;

EID: 0030459760     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199612000-00006     Document Type: Article

References (33)

1. Ivy AC, Oldberg E. Hormone mechanism for gall bladder contraction and evacuation. J Physiol (Lond) 1928;86:599-613.
2. Zetler G. Neuropharmacological profile of cholecystokinin-like peptides. In: Vanderhaegen JJ, Crawly JN, eds. Neuronal cholecystokinin (annals ser. vol. 448). New York: New York Acadamy of Sciences, 1985:119-469.
3. Flood JF, Smith GE, Morley JE. Modulation of memory processing by cholecystokinin: dependence on the vagus nerve. Science 1987;236:832-4.
4. Vanderhaegen JJ, Signeau JC, Gepts W. New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature 1975; 264:568-70.
5. Bouras C, Magistretti PJ, Morrison JH. An immunohistochemical study of six biologically active peptides in the human brain. Human Neurobiol 1986;5:213-26.
6. Katsuura G, Itoh S. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats. Peptides 1986;7:105-10.
7. Itoh S, Takashima A, Katsuura G. Preventive effect of cholecystokinin octapeptide on scopolamine-induced memory impairment in the rat. Drug Dev Res 1988;12:63-70.
8. Itoh S, Takashima A, Igano K, Inouye K. Memory effect of caerulein and its analogs in active and passive avoidance responses in the rat. Peptides 1989;10:843-8.
9. Itoh S, Takashima A, Maeda Y. Memory impairments induced by peripherally administered cholecystokinin A-type receptor antagonist in rats. Drug Dev Res 1992;26:89-99.
10. Meziane H, Devigne C, Tramu G, Soumireu-Mourat B. Effects of anti-CCK-8 antiserum on acquisition and retrieval by mice in an appetitive task. Peptides 1993;14:67-73.
11. Harro J, Oreland L. Age-related differences of cholecystokinin receptor binding in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:369-75.
12. Harro J, Marcusson J, Oreland L. Alterations in brain cholecystokinin receptors in suicide victims. Eur Neuropsychopharmacol 1992;2:57-63.
13. Farmery SM, Owen F, Poulter M, Crow TJ. Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patients. Life Sci 1985;36:473-7.
14. Ferner FN, Cross AJ, Johnson JA, Robert GW, Crow TJ, Corsellis JA, Lee YC, O'Shaugnessy D, Adrian TE, McGregor GP. Neuropeptides in Alzheimer type dementia. J Neurol Sci 1983;62:159-70.
15. Mazurek MF, Beal MF. Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex. Neurology 1991;41:716-9.
16. Schreiber H, Stolz-Born G, Pietrowsky R, Komhuber HH, Fehm HL, Born J. Improved event-related potential signs of selective attention after the administration of the cholecystokinin analog ceruletide in healthy persons. Biol Psychiatry 1995;37:702-12.
17. Pietrowsky R, Thiemann A, Kern W, Nustede R, Fehm HL, Born J. A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin. Psychoneuroendocrinology 1996, in press.
18. Näätänen R, Picton T. The N1 wave of the human electric and magnetic response to sound: a review and an analysis of the component structure. Psychophysiology 1987;24:375-425.
19. Näätänen R, Gaillard AWK The orienting reflex and the N2 deflection of the event-related potential (ERP). In: Gaillard AWK, Ritter W, eds. Tutorials in ERP research: endogenous components. Amsterdam, North Holland: Elsevier, 1983:119-41.
20. Donchin E. Surprise!..Surprise? Psychophysiology 1981;18:493-513.
21. Verleger R. Event-related potentials and cognition: a critique of the context updating hypothesis and an alternative interpretation of P3. Behav Brain Sci 1988;11:343-427.
22. Kok A, Zeef E. Arousal and effort: a review and theoretical synthesis of studies of age-related changes in event-related potentials. In: Brunia CHM, Mulder G, Verbaten MN, eds. Event-related brain research (EEG suppl. 42). Amsterdam: Elsevier, 1991: 324-41.
23. Goodin DS, Squires KC, Henderson BH, Starr A. Age related variations in evoked potentials to auditory stimuli in normal human subjects. Electroencephalogr Clin Neurophysiol 1978;44:447-58.
24. Pfefferbaum A, Ford JM, Wenegrat BG, Roth WT, Kopell BS. Clinical applications of the P3 component of event-related potentials. I. Normal aging. Electroencephalogr Clin Neurophysiol 1984;59: 85-103.
25. Verleger R, Neukäter W, Kömpf D, Vieregge P. On the reasons for the delay of P3 latency in healthy elderly subjects. Electroencephalogr Clin Neurophysiol 1991;79:488-502.
26. Pfefferbaum A, Wenegrat BG, Ford JM, Roth WT, Kopell BS. Clinical applications of the P3 component of event-related potentials. II. Dementia, depression and schizophrenia. Electroencephalogr Clin Neurophysiol 1984;59:104-24.
27. Donchin E, Coles MGH. Is the P300 component a manifestation of context updating? Behav Brain Sci 1988;11:357-74.
28. Johnson R, Donchin E. Second thoughts: multiple P300s elicited by a single stimulus. Psychophysiology 1985;22:182-94.
29. Ruchkin DS, Sutton S, Kietzman MLL, Silver K. Slow wave and P300 in signal detection. Electroencephalogr Clin Neurophysiol 1980;50:35-47.
30. Kutas M. Review of event-related potential studies of memory. In: Gazzaniga MS, ed. Perspectives in memory research. Cambridge: MIT Press, 1988:181-217.
31. Ermisch A, Brust P, Kretzschmar R, Rühle HJ. Peptides and blood-brain-barrier transport. Physiol Rev 1993;73:489-527.
32. Wood CC, Allison T, Goff WR, Williamson PD, Spencer DD. On the neural origin of P300 in man. In: Komhuber HH, Deecke L, eds. Motivation, motor and sensory processes of the brain. Amsterdam: Elsevier, 1980:51-6.
33. Rutecki P. Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia 1990;31[suppl 2]:S1-S6.